News

Supriya Lifescience Limited will seek shareholder approval for a final dividend of Re. 1.00 per equity share of Rs 2 each for the fiscal year 2025-26 at its Annual General Meeting scheduled for September 24, 2026, and has set September 4, 2026, as the record date for determining member entitlement.

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 13 August 2026.

Supriya Lifesciences announced that the Board of Directors of the Company at its meeting held on 27 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Net profit of Supriya Lifescience rose 47.34% to Rs 74.23 crore in the quarter ended March 2026 as against Rs 50.38 crore during the previous quarter ended March 2025. Sales rose 50.20% to Rs 276.53 crore in the quarter ended March 2026 as against Rs 184.11 crore during the previous quarter ended March 2025.For the full year,net profit rose 11.26% to Rs 209.12 crore in the year ended March 2026 as against Rs 187.96 crore during the previous year ended March 2025. Sales rose 18.86% to Rs 827.88 crore in the year ended March 2026 as against Rs 696.49 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales276.53184.11 50 827.88696.49 19 OPM %35.3036.71 -35.5237.44 - PBDT100.6370.14 43 303.65268.93 13 PBT92.1364.06 44 275.24248.49 11 NP74.2350.38 47 209.12187.96 11 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 27 May 2026.